BioSpace News Archive

Each year, St. Mary’s General Hospital Foundation hosts RedDAY to raise awareness of the serious risk of heart disease in women, rallying people, workplaces and community leaders from across Waterloo Region to mark the day by wearing red and sharing images on social media with the hashtag #RedDayFriday.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the New England Journal of Medicine (NEJM) published positive data from the Phase 3 PREVENT study of SOLIRIS® (eculizumab), a first-in-class complement inhibitor, in adult patients with anti-aquaporin-4 (AQP4) auto antibody-positive neuromyelitis optica spectrum disorder (NMOSD)

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company TerrAscend Corp. (“TerrAscend”) (CSE: TER) (OTCQX: TRSSF) on its announcement yesterday that its facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice (“GMP”) certificate in accordance with the rules governing medicinal products in the European Union (

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in the business and reported financial results for the quarter ended March 31, 2019.

The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to confirm that the Hamilton City Council and the Company have finalized and signed a settlement offer, and that the Local Planning Appeal Tribunal approved the settlement at a meeting on May 2, 2019.

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the schedule of presentations on BIJUVATM (estradiol and progesterone capsules, 1 mg/100 mg) and ANNOVERA™ (segesterone acetate/ethinyl estradiol vaginal system) at the American College of Obstetricians and Gynecologists (ACOG) 2019 Annual Meeting in Nashville on May 3-6, 2019

PROCEPT® BioRobotics, a Silicon Valley surgical robotics company, announced today that the American Urological Association (AUA) has amended its surgical practice guidelines to include Aquablation® therapy as a standard of care treatment for male lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or enlarged prostate.

Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced a poster presentation at the 2019 American Academy of Neurology (AAN) Annual Meeting in Philadelphia, Pa.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that results from the pivotal rimegepant Zydis® ODT Phase 3 clinical trial will be presented as a late-breaking oral presentation at the 2019 American Academy of Neurology (AAN) Annual Meeting in Philadelphia, May 4-10, 2019.

Constipation affects 25 to 30% of young children2 which means approximately one in three children will struggle with this condition.